Wiltrom Co. Ltd. · TPEX:6767
Wiltrom — Investor Presentation (October 2025)
36 slides from Wiltrom's investor presentation, October 2025
Slide 1: Wiltrom Co., Ltd
6767 Wiltrom Co., Ltd 0
Slide 2: Disclaimer
Disclaimer The predictive information mentioned in this briefing report and the related information released at the same time, including operating outlook, financial status and business forecasts, is the information obtained by the company based on internal data and the overall external economic d
Slide 3: Report to the investment leaders about the risks and regulations
Report to the investment leaders about the risks and regulations： Risk item Industry risk and operational risk： Please refer to the Risk Disclosure Instructions page 1-2,and the Cash Capital Increase Instructions “ The company's industry, operations and other important risks ”. Other important r
Slide 4: Chapter of risk item
Chapter of risk item Please refer to the Risk Disclosure Instructions page 9-10,and the Cash Capital Increase Instructions “ The company’s industry, operations and other important risks ” . It′s about the company faces the competition from major international companies risk, solutions and evaluati
Slide 5: Chapter of special item
Chapter of special item Please refer to the Risk Disclosure Instructions page 12-45,and the Cash Capital Increase page 104-133. It′s about the company′s performance, development and evaluation opinions of securities firms. Please refer to the Risk Disclosure Instructions page 45-47,and the Cash
Slide 6: Outline
Outline I. Company profile II. Market overview and core technology platform III. Business performance VI. Business development strategy and future prospects 5
Slide 7: Company profile
Company profile Stock Num: 6767 Company Name Wiltrom Co., Ltd Establish Date 2009/12/18 1F., No.26, Sec. 2, Shengyi Rd., Zhubei City, Address Hsinchu County, 30261, Taiwan (R.O.C.) +886 3 6107168 Capital NTD$ 263,900,000 President &General Dr. Huang-Chien Liang Manager: Spinal Fixation System, Inter
Slide 8: Management Board Introduction
Management Board Introduction As of 10/31/2020 Title Name Curriculum Vitae Ph.D., in Chemical Engineering, National Tsing Hua University(NTHU) Chairman Huang-Chien Liang Researcher, Project Director, Biomedical Technology and Device Research Laboratories, ITRI M.S., Life Science, National Tsin
Slide 9: Management team
經營團隊 President&General Manager Operation Management Ministry of Law Research and Development General Administration Sales & Marketing Department, Director Department, Director Department, Manager Department, Manager Department Manager PHD. Huang-Chien PHD. Hung-Ying, Tai Jessica Hsiao Rita Tsai Jack
Slide 10: Milestone
Milestone 2018 2020 2014 2019 2009 2016 The first Taiwanese brand company get TFDA approval of First Taiwan spine private Spine Minimally label enters US market Passed the OTC application Invasive fixation First to develop patented system technology "Vertebral Body ITRI Technology Extension Augmenta
Slide 11: Starting from Taiwan, enhancing international vision and building brand image
全球布局與銷售據點 Wiltrom Inc TAIWAN Taiwan Headquater, Biomedical Science Park(2009) Wiltrom Co., Ltd was established in 2009, and its products are under its own brand sales in more than 10 countries in the world. Customers in Europe, Asia, America and Africa. Starting from Taiwan, enhancing internationa
Slide 12: Company philosophy and vision
Company philosophy and vision • Core Value Innovation、Honesty、Health • Mission Provide safe and effective spinal innovative treatment methods, and jointly create health and well-being • Vision Become a leading company to provide total solution of spinal minimally invasive surgery solutions 11
Slide 13: Outline
Outline I. Company profile II. Market overview and core technology platform III. Business performance VI. Business development strategy and future prospects 12
Slide 14: Spinal surgery related product market size
市場概況-脊椎手術相關產品市場規模 $ Million USD 8,290 Million 1,950 Million 1,520 Million 1,320 Million Spinal Fusion Vertebral Compression Spinal Non-Fusion Bone cement Surgery Frx Surgery Surgery Liquid Liquid Powder Global Spinal Fusion Global VCF Device Market Spinal Non-Fusion Surgery Surgery Market Markey Bon
Slide 15: Innovative R&D integration platform
創新研發整合平台 Market value, patent 3 Outer resource regulations, medical insurance system Produ 2 Experts analysis Safety Analysis Regulations ct Clinical 1 Material design 4 5 Com Unmet platform Need merci Mechanism design platform alized <Platform Features> 1. Continue to screen for valuable clinical u
Slide 16: Product Portfolio
Product Portfolio Vertebral Compression Spinal fusion surgery Frx. Surgery Bone Cement Spinal Fixation System Vertebral Bone Cement Augmentation System Interbody Fusion System Bone Graft Substitute 15
Slide 17: Development Trend of Spinal Fixation Surgery
Development Trend of Spinal Fixation Surgery Currently Clinical Unmet Need Percutaneous MIS Spinal How to complete spinal fusion surgery Open Surgery under a single small wound, implant spinal fusion surgery fixators, intervertebral fusion cages, and artificial replacement bones, shorten the patient
Slide 18: MIS Single-incision spinal fixation system
MIS Single-incision spinal fixation system The minimally invasive single-wound spinal fusion system can reduce the wound to 1.8cm, and achieve the completion of the operation under a single small wound in a limited field of view and operation area, shorten the patient's hospital stay and improve the
Slide 19: Product competition niche-spinal fusion surgery related products
Product competition niche-spinal fusion surgery related products Item Wiltrom S company M company MIS Single-incision spinal fixation systehigh Picture Number of incision 1 4 1 Wound 1.8-3 cm 10.7± 1.5cm 7.3± 0.9cm Blood loss 50-100cc 100-500cc 360± 30cc Surgical method Single incision Extra incisio
Slide 20: Development Trend of Vertebral compression fracture surgery
Development Trend of Vertebral compression fracture surgery Clinical Unmet NeedNeed to effectively provide vertebral body reduction and stabilize the vertebral body 85% 13% 2% The Spine Journal , 2015, 15, 281–289 Vertebroplasty Kyphoplasty Maintain the physiological curve of the spine and change
Slide 21: Vertebral Body Augmentation System (Tripod-Fix)
Vertebral Body Augmentation System(Tripod-Fix) The world's first corrective reduction for front-end compression fractures, effectively providing the reduction height of the vertebral body (21.0 ± 4.4%), avoiding the continued collapse of the vertebral body, and achieving the purpose of solving back
Slide 22: Product competition niche- Vertebral compression fracture surgery
Product competition niche- Vertebral compression fracture surgery Item Wiltrom S company M company Tripod-Fix Vertebral Body Augmentation System Picture Material Titanium Titanium PE Vertebral height 21 ± 4 12 ± 13 0± 7 restoration rate Bone cement Low low medium leakage% Recollapse % Low Low high P
Slide 23: Bone cement
Bone cement Wiltrom uses process technology to stably control the particle size distribution of the powder, overcome the technical bottleneck of bone cement development, and sell it with vertebral spreaders to increase product penetration. It is one of the few medical equipment manufacturers in Asia
Slide 24: Product competition niche-Bone Cement
Product competition niche-Bone Cement item Wiltrom T 公司 H 公司 Bone Cement Visicosity medium medium Medium Temperature 60C-65C 70C-75C 60C-70C Time 20-30 mins 20-30 mins 20-30 mins Application time 10 mins 15 mins 10mins Development high high high effect price high high high IFU 23
Slide 25: Outline
Outline I. Company profile II. Market overview and core technology platform III. Business performance VI. Business development strategy and future prospects 24
Slide 26: Develop research and development results with product differentiation
Develop research and development results with product differentiation 2014 2016 2017 2018 2019 2020 Bone Cement Tripod-Fix Bone-filling cage Single-incision spinal fixation system Saber-tooth interbody fusion system MIS spinal fixation system 25
Slide 27: Award
Award No. Awards Time Description 1 2012 SBIR R&D Alliance Award 101 Innovation lumbar spine fusion and fixation system product technology The 11th National New Innovation Award Enterprise Group / R & D Non-fusion minimally invasive spinal intervertebral annulus repair 2 Technology 103 technique 3 2
Slide 28: 2020 Outstanding Biotechnology Industry Award
2020 Outstanding Biotechnology Industry Award-Annual Industry Innovation Award 27
Slide 29: R & D performance
R & D performance 61 patent acquisition and application status (as of December 18, 109) patent Number of Number of item Patent Patent Application Invention PATENT Other Invention PATENT coun Austral Taiwan USA China Taiwan USA China Taiwan USA China Europe Japan Korea try ia Num 13 5 3 4 2 2 6 6 9 6
Slide 30: Sales performance
Sales performance Domestic and foreign sales ratio (108 years)- 76:24 Foreign markets: Sales to more than ten countries including the United States, China, the Philippines, Malaysia, Mexico... Domestic market: adopted by all major medical centers in Taiwan TAIWAN 29
Slide 31: Sales revenue and growth momentum
Sales revenue and growth momentum 單位：新台幣仟元 合併營收成長率 Growth Rate 國內自費產品營收及成長率 Self-paid product sales revenue in TW market 120,000 40,000 成長率 成長率 成長率 157.7% 30,000 159.0% 52.0% 100,000 27,544 成長率 20,000 23,268 80,000 25.8% 10,000 8,985 75,261 72,372 0 60,000 107年度 108年度 109年Q3 59,829 40,000 國內直營醫院營收及成
Slide 32: Outline
Outline I. Company profile II. Market overview and core technology platform III. Business performance VI. Business development strategy and future prospects 31
Slide 33: Global Operation Strategy (1/2)
Global Operation Strategy (1/2) 01. Differentiated innovative products (technology transfer) U.S.. China. European market For differentiated innovative products, clinical trials Technology transfer as the mainstay, (Tripod-Fix) are required before listing and access as a supplement A successful
Slide 34: Global Operation Strategy (2/2)
Global Operation Strategy (2/2) 01. Establish brand image and value • Participate in exhibitions of domestic and foreign medical Taiwan, Southeast Asia, associations Central and South America and other markets Channels are the mainstay, • Physician education and training activities technology transf
Slide 35: Future product development strategy
Future product development strategy Extension/continuity Spinal fusion products development products Precision medicine (AI navigation surgical robot) Vertebral 3D printing composite Innovative R&D compression Core technology extension integration fracture product products platform New R&D product S
Slide 36: Thanks for your attention
Thanks for your attention > . WUTEEFOM sec: sestn exis: